出典: meddic

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/06/08 10:33:28」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Computational design, functional analysis and antigenic epitope estimation of a novel hybrid of 12 peptides of hirudin and reteplase.
  • Cai Y1, Bao J, Lao X, Zheng H, Chen J, Yu R.
  • Journal of molecular modeling.J Mol Model.2015 Sep;21(9):229. doi: 10.1007/s00894-015-2774-2. Epub 2015 Aug 13.
  • Cardiovascular and cerebrovascular diseases are leading causes of morbidity and mortality for human beings, and thrombosis is the major risk factor. Thrombolytic therapy has been testified to be the most effective approach to cure thrombosis-related diseases. In clinical treatment, we often adopt a
  • PMID 26267298
  • Stuck aortic valve treated by reteplase in a Bentall patient.
  • Tanyeli Ö1, Dereli Y, Düzenli MA, Görmüş N.
  • Anatolian journal of cardiology.Anatol J Cardiol.2015 Apr;15(4):339-40. doi: 10.5152/akd.2015.6024.
  • PMID 25880294
  • Approach to thrombotic occlusion related to long-term catheters of hemodialysis patients: a narrative review.
  • Mendes ML1, Barretti P1, da Silva TN1, Ponce D1.
  • Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.J Bras Nefrol.2015 Apr-Jun;37(2):221-7. doi: 10.5935/0101-2800.20150035.
  • Currently, permanent catheters (pCVC) are becoming an alternative vascular access for long-stay patients in whom arteriovenous access cannot be made. Occlusion is a commun mechanical complication related to pCVC, leading to inadequate dialysis dose and frequent changes of local catheter location, wh
  • PMID 26154643


  • Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke : An open-label, dose-ranging phase I study
  • Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in actute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) trial.
  • Thrombolysis With Reteplase, an Unglycosylated Plasminogen Activator Variant, in Experimental Embolic Stroke
  • Journal of stroke and cerebrovascular diseases : official publication of the National Stroke Association 7(3), 179-186, 1998-06-01
  • NAID 10016095479


For patient information regarding reteplase, click here. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Alejandro Lemor, M.D. [2] Disclaimer WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc ...
reteplase /ret·e·plase/ (ret´ĕ-plās) a recombinant form of tissue plasminogen activator; used as a thrombolytic agent in the treatment of myocardial infarction. reteplase [ret′ĕ-plās] a recombinant form of tissue plasminogen activator ...


Reteplase - drug review: dosage, side Package Label — Principal Display Panel Reteplase (r-PA)Excel Healthcare laboratories (Pvt) Ltd  retavase reteplase vs alteplase reteplaseReteplase